Organogenesis Holdings Inc (ORGO)
3.135
+0.04
(+1.13%)
USD |
NASDAQ |
Jan 06, 16:00
3.135
0.00 (0.00%)
After-Hours: 16:02
Organogenesis Holdings Shareholders Equity (Quarterly): 278.55M for Sept. 30, 2024
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Plus Therapeutics Inc | -5.174M |
| Poseida Therapeutics Inc | 87.21M |
| NovaBay Pharmaceuticals Inc | 1.072M |
| Palatin Technologies Inc | -7.686M |
| iBio Inc | 17.75M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 446.30M |
| Total Liabilities (Quarterly) | 167.75M |
| Debt to Equity Ratio | 0.223 |
| Current Ratio | 3.086 |
| Net Debt Paydown Yield | 0.36% |